NU SKIN ENTERPRISES, INC.NUSEarnings & Financial Report
Nu Skin Enterprises, Inc. is an American multilevel marketing company that develops and sells personal care products and dietary and nutritional supplements. Under the Nu Skin and Pharmanex brands, the company sells its products in 54 markets through a network of approximately 1.2 million independent distributors.
NUS Q1 FY2026 Key Financial Metrics
Revenue
$320.6M
Gross Profit
$214.5M
Operating Profit
$110.2M
Net Profit
$1.8M
Gross Margin
66.9%
Operating Margin
34.4%
Net Margin
0.6%
YoY Growth
-12.0%
EPS
$0.04
NU SKIN ENTERPRISES, INC. Q1 FY2026 Financial Summary
NU SKIN ENTERPRISES, INC. reported revenue of $320.6M (down 12.0% YoY) for Q1 FY2026, with a net profit of $1.8M (0.6% margin). Cost of goods sold was $106.1M, operating expenses totaled $104.3M.
Key Financial Metrics
| Total Revenue | $320.6M |
|---|---|
| Net Profit | $1.8M |
| Gross Margin | 66.9% |
| Operating Margin | 34.4% |
| Report Period | Q1 FY2026 |
NU SKIN ENTERPRISES, INC. Annual Revenue by Year
NU SKIN ENTERPRISES, INC. annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.5B).
NU SKIN ENTERPRISES, INC. Quarterly Revenue & Net Profit History
NU SKIN ENTERPRISES, INC. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $320.6M | -12.0% | $1.8M | 0.6% |
| Q4 FY2025 | $370.3M | -16.9% | $14.5M | 3.9% |
| Q3 FY2025 | $364.2M | -15.3% | $17.1M | 4.7% |
| Q2 FY2025 | $386.1M | -12.1% | $21.1M | 5.5% |
| Q1 FY2025 | $364.5M | -12.7% | $107.5M | 29.5% |
| Q4 FY2024 | $445.6M | -8.8% | $-36.1M | -8.1% |
| Q3 FY2024 | $430.1M | -13.8% | $8.3M | 1.9% |
| Q2 FY2024 | $439.1M | -12.2% | $-118.3M | -26.9% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $439.1M | $430.1M | $445.6M | $364.5M | $386.1M | $364.2M | $370.3M | $320.6M |
| YoY Growth | -12.2% | -13.8% | -8.8% | -12.7% | -12.1% | -15.3% | -16.9% | -12.0% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $1.59B | $1.58B | $1.47B | $1.39B | $1.44B | $1.42B | $1.41B | $1.38B |
| Liabilities | $899.8M | $876.0M | $817.5M | $637.4M | $655.9M | $624.6M | $600.1M | $582.7M |
| Equity | $686.2M | $706.9M | $651.5M | $754.0M | $787.8M | $799.8M | $805.2M | $794.1M |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $51.2M | $31.4M | $25.8M | $389000 | $35.8M | $27.5M | $16.6M |